[Effect of chondroprotectors in the treatment and prophylaxis of the knee joint osteoarthrosis].
An analysis is presented of employment of hyalgan (1% solution of hyaluronic acid) in 29 patients with osteoarthrosis of the knee joint (KJOA). The patients were divided into three groups. Group I comprized 9 patients with prior arthroscopic interventions in the knee joint with stage I KJOA; group II was 5 patients having undergone plasty of the anterior cruciate ligament with stage I KJOA; group III was 15 patients with stage II-III KJOA. Hyalgan (20 mg) was administered once per week for 5 weeks. Intensity of the pain syndrome was assessed by using a visual-analogue scale together with time-related thermal gradient with the aid of the remote infrared thermography technique. Hyalgan enhances efficiency of treatment of KJOA.
Zazirnyĭ
I M
IM
Mahomedov
O M
OM
Drobotun
O V
OV
Ievseienko
V H
VH
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D007270:Injections, Intra-Articular; D008297:Male; D008875:Middle Aged; D020370:Osteoarthritis, Knee / Q000188:drug therapy* / Q000378:metabolism / Q000517:prevention & control*; D010147:Pain Measurement; D013817:Thermography; D016896:Treatment Outcome
D006820:Hyaluronic Acid